53
19) Smith and Jones, CPAs, audited the consolidated financial statements of Concord Inc. and all
but one of its subsidiaries for the year ended September 30, 2016 and are expressing an
unqualified opinion on the financials presented as a whole.
Smith, the engagement partner, instructed Mary, an assistant on the engagement, to draft the
auditor’s report on November 4, 2016, the date of fieldwork completion. In drafting the report
Mary considered the following:
• In preparing its financial statements, Concord changed its method of accounting for research
and development costs and properly expensed these amounts. Management described the change
in principle in Note 10 to the consolidated financial statements.
• Ball & Brown, CPAs, audited the financial statements of Biotherm, Inc., a consolidated
subsidiary of Concord for the year ended September 30, 2016. The subsidiary’s financial
statements reflect total assets of 22% and total revenues of 20% of the consolidated totals. Ball &
Brown expressed an unqualified opinion and furnished to Smith & Jones a copy of their auditor
report. Smith & Jones have decided not to assume responsibility for the work of Ball & Brown
insofar as it relates to the expression of an opinion on the consolidated financial statements taken
as a whole because of the materiality of Biotherm’s financial statements to the consolidated
whole. Ball & Brown’s report will not be presented together with that of Smith & Jones.
• Concord is the subject of a grand jury investigation into possible violations of federal
antitrust laws and possible related crimes. Related civil class actions are pending. Concord’s
management has adequately disclosed in Note 12 to their consolidated financial statements.
Because of the early stage of the investigation, the ultimate outcome of these matters cannot be
determined at this time. Therefore, no provision for any liability that may result has been
recorded.
• Concord experienced a net loss in 2016 and is currently in default under substantially all of
its debt agreements. Management’s plans in regard to these matters are adequately disclosed in
Note 14 to Concord’s consolidated financial statements. The financials do not include any
adjustments that might result from the outcome of this uncertainty. These matters rase substantial
doubt about Concord’s ability to continue as a going concern.
Ball reviewed Mary’s draft and indicated in his review notes that there were many deficiencies in
Mary’s Draft. The audit report that Mary drafted follows.
Independent Auditor’s Report
We have audited the consolidated financial statements of Concord, Inc., and subsidiaries as of
September 30, 2016, and the related consolidated statements of income, changes in stockholders
equity and cash flows for the year then ended. These financial statements are the responsibility of
the Company’s management. Our responsibility is to express an opinion on these financial
statements based on our audits. We did not audit the financial statements of Biotherm, Inc., a
wholly-owned subsidiary, which statements reflect total assets and revenues constituting 22%
and 20% respectively at September 30, 2016 of the consolidated totals. Those statements were
audited by Ball & Brown, CPAs, whose reports have been furnished to us, and our opinion,
insofar as it relates to the amounts included for Biotherm, Inc. is based solely on their report.